Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Cash Flow Reinvestment Rate
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥11.85 Million (capex CN¥11.85 Million ) from operating cash flow of CN¥58.18 Million. Check Qianjiang Yongan Pharmaceutical Co Ltd (002365) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Explore Qianjiang Yongan Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Qianjiang Yongan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002365 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.77x | CN¥186.81 Million | CN¥105.71 Million | CN¥118.04 Million | ▲ +128.2% |
| 2023 | 0.77x | CN¥189.15 Million | CN¥244.26 Million | CN¥120.74 Million | ▲ +16.4% |
| 2022 | 0.67x | CN¥257.76 Million | CN¥387.28 Million | CN¥149.07 Million | ▼ -58.9% |
| 2021 | 1.62x | CN¥165.02 Million | CN¥101.81 Million | CN¥63.05 Million | ▼ -4.6% |
| 2020 | 1.70x | CN¥351.06 Million | CN¥206.66 Million | CN¥104.41 Million | ▲ +98.9% |
| 2019 | 0.85x | CN¥204.59 Million | CN¥239.55 Million | CN¥134.39 Million | ▼ -38.0% |
| 2018 | 1.38x | CN¥432.37 Million | CN¥314.02 Million | CN¥269.50 Million | ▼ -11.4% |
| 2017 | 1.55x | CN¥306.65 Million | CN¥197.32 Million | CN¥289.47 Million | ▲ +29.0% |
| 2016 | 1.20x | CN¥101.83 Million | CN¥84.53 Million | CN¥40.13 Million | ▲ +149.3% |
| 2015 | 0.48x | CN¥34.12 Million | CN¥70.61 Million | CN¥34.12 Million | ▼ -81.6% |
| 2014 | 2.63x | CN¥50.69 Million | CN¥19.26 Million | CN¥50.69 Million | ▲ +67.6% |
| 2013 | 1.57x | CN¥99.93 Million | CN¥63.65 Million | CN¥99.93 Million | ▼ -7.6% |
| 2012 | 1.70x | CN¥120.18 Million | CN¥70.75 Million | CN¥120.18 Million | ▼ -37.5% |
| 2011 | 2.72x | CN¥248.03 Million | CN¥91.23 Million | CN¥248.03 Million | ▲ +14.6% |
| 2010 | 2.37x | CN¥104.52 Million | CN¥44.06 Million | CN¥104.52 Million | ▲ +87.9% |
| 2009 | 1.26x | CN¥45.98 Million | CN¥36.43 Million | CN¥45.98 Million | ▲ +177.0% |
| 2008 | 0.46x | CN¥72.19 Million | CN¥158.47 Million | CN¥72.19 Million | ▼ -54.2% |
| 2007 | 0.99x | CN¥60.77 Million | CN¥61.08 Million | CN¥60.77 Million | ▲ +75.1% |
| 2006 | 0.57x | CN¥17.68 Million | CN¥31.11 Million | CN¥17.68 Million | — |